Acceleron pharma inc (XLRN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating Activities
Net loss

-50,939

-23,575

-45,370

-17,860

-38,053

-34,735

-28,980

-28,937

-26,219

-27,928

-25,451

-29,668

-25,407

-19,289

-20,769

-22,017

5,061

-27,082

-11,857

-10,381

-14,574

-17,617

-7,972

-16,550

-9,120

-18,110

-18,513

13,078

1,647

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

996

968

990

1,009

933

832

1,002

962

904

777

799

683

541

518

443

391

324

305

297

283

291

286

290

277

265

234

232

225

224

Loss on disposition of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-14

-25

0

0

0

-

-

-

-

Stock-based compensation

6,679

5,685

5,306

5,012

6,992

6,507

6,407

5,959

5,696

6,371

5,705

9,589

6,583

5,170

4,587

4,552

4,248

3,780

3,064

2,659

2,572

1,451

1,195

1,114

1,018

755

493

520

428

Accretion of deferred interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-536

85

86

85

86

Amortization of deferred debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

36

4

5

159

18

Change in fair value of warrants

-

-

-

-

-

-

-

-

-

-

411

227

45

-2,236

793

2,864

-8,683

9,123

-2,616

-2,557

-422

3,087

-3,394

-740

-3,990

14,226

11,149

433

1,067

Net amortization of premium on investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

332

100

-

-

-264

1,041

0

0

0

0

-

-

-

-

Other non-cash items

-1,365

-203

479

555

-959

675

-275

-721

-88

-957

-66

-57

-88

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on retirement of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

76

Changes in assets and liabilities:
Prepaid expenses and other assets

-828

-1,302

1,223

2,271

237

360

-429

2,306

749

1,101

256

-904

222

200

592

-80

699

-106

747

-814

166

-1,468

1,767

495

-539

61

800

-310

272

Collaboration receivables (all amounts are with a related party)

-112

1,672

1,428

2,667

-4,259

3,782

-411

437

-338

691

-2

-689

336

215

-220

182

-571

-322

-1,336

1,237

682

139

-503

1,098

-983

-487

-237

1,341

223

Non-cash lease expense

1,377

1,339

1,302

1,268

1,234

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2

2

Accounts payable

1,634

441

-1,694

-337

3,466

-753

-103

-408

591

62

-637

849

-778

-552

1,505

-267

-42

-1,772

857

223

843

-2,590

700

319

1,410

-296

-71

561

-247

Accrued expenses

-7,148

1,126

6,876

2,800

-4,544

3,767

277

2,093

-4,233

1,333

2,345

-234

-1,951

135

914

-654

129

2,939

664

1,537

-164

906

-505

1,860

-2,278

2,311

404

-1,262

-744

Operating lease obligations

1,466

2,119

1,340

557

1,317

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other changes in operating assets and liabilities

-17

-10

-15

42

0

-124

-186

-202

-153

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-135

-135

-137

-135

-134

-136

-144

-176

-205

-432

-371

-371

-281

-347

-674

-905

-638

-22,890

-2,516

Deferred rent

-

-

-

-

-

-

-

-

-

-

333

-122

-189

2

-190

-189

473

873

-110

-369

125

125

124

125

125

126

123

125

125

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-50

1

199

0

-106

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-46,545

-16,251

-37,045

-14,200

-26,308

-29,028

-20,096

-22,151

-23,431

-20,802

-16,818

-17,161

-21,763

-16,590

-13,022

-15,872

939

-12,461

-8,977

-8,948

-13,825

-13,619

-16,356

-10,773

-12,472

-1,364

-7,539

-10,012

-735

Investing Activities
Purchases of investments

10,454

16,042

85,183

77,797

216,116

0

7,457

30,166

35,947

179,690

70

-46

221

85,749

-28,233

35,274

125,524

369

1,619

8,493

124,216

0

0

0

0

-

-

-

-

Proceeds from sales and maturities of investments

88,361

98,876

124,057

40,068

64,133

60,456

53,084

61,017

24,530

33,964

35,780

16,688

33,533

91,769

-23,058

25,082

19,096

-3,453

15,153

14,985

0

-

-

-

-

-

-

-

-

Purchases of property and equipment

426

1,121

893

686

587

689

528

869

504

757

711

2,251

677

1,134

686

1,071

489

300

415

86

158

16

119

229

150

120

62

45

80

Net cash provided by (used in) investing activities

77,481

81,713

37,981

-38,415

-152,570

59,767

45,099

29,982

-11,921

-146,483

34,999

14,483

32,635

4,886

4,489

-11,263

-106,917

-4,122

13,119

6,406

-124,374

-16

-119

-229

-150

-120

-62

-45

-80

Financing Activities
Payments made to repurchase redeemable convertible preferred stock, common stock and warrants to purchase common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

300

Proceeds from issuance of common stock from public offering, net of issuance costs

0

0

0

-25

248,155

0

0

0

0

-

-

-

-

0

306

-369

140,760

-47

0

0

0

-

-

-

-

-

-

-

-

Payments for withholding taxes on restricted stock units

-

-

-

-

-

-

-

-

-

-

86

0

140

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock from public offering, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

0

129,166

-

-

-

-

Proceeds from issuance of common stock from private placements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Payments of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

0

16,332

-

-

-

-

Proceeds from issuances of common stock related to employee stock purchase plan

-

-

-

-

-

-

-

-

-

-

317

0

510

0

274

0

384

-1

283

0

307

-

-

-

-

-

-

-

-

Payments for capital lease expenditures

-

-

-

-

-

-

0

0

78

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and warrants to purchase common stock

-

-

-

-

-

-

-

-

-

-

1,835

247

1,151

1,788

1,974

818

732

976

857

884

1,246

839

1,472

1,117

760

603

24

12

14

Payments for capital lease expenditures

-

-

-

-

-

61

0

0

78

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from exercises and vesting of stock awards, ESPP contributions, and exercise of warrants to purchase common stock

8,873

2,673

4,997

1,759

1,161

947

8,297

2,025

5,016

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

8,873

2,673

4,997

1,734

249,316

886

8,297

2,025

4,938

28,476

190,052

247

1,521

1,788

2,554

449

141,876

928

1,140

884

1,553

839

1,481

1,117

113,594

-1,832

95,615

12

-286

Net increase in cash, cash equivalents and restricted cash

39,809

68,135

5,933

-50,881

70,438

31,625

33,300

9,856

-30,414

-138,809

208,233

-2,431

12,393

-9,916

-5,979

-26,686

35,898

-15,655

5,282

-1,658

-136,646

-12,796

-14,994

-9,885

100,972

-3,316

88,014

-10,045

-1,101

Supplemental Disclosure of Cash Flow Information:
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,574

395

412

415

435

Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Accretion of dividends, interest, redemption value, and issuance costs on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

6,271

6,843

6,756

Capitalized follow-on public offering costs included in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

369

-

-

-

0

-

-

0

8

-

-

-

-

Purchase of property and equipment included in accounts payable and accrued expenses

425

-

-

-

267

-

-

-

314

-201

90

-1,464

1,769

372

-233

-195

453

188

-75

149

8

4

-32

-44

83

-

-

-

-

Reclassification of warrant liability to additional paid-in capital

-

-

-

-

-

-

-

-

797

-

0

0

0

-

-

-

-

-

-

-

-

-

3,090

3,690

821

-

1,335

0

678

Acquisition of capital lease

-

-

-

-

-

-

-

-

139

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-